Welcome to our dedicated page for Sabra Health Care REIT SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sabra Health Care REIT, Inc. filings document the reporting obligations of a Nasdaq-listed healthcare REIT that owns and invests in healthcare real estate through subsidiaries. Its 8-K reports cover operating results, supplemental information packages, non-GAAP financial measure reconciliations, Regulation FD materials, capital-structure events and material definitive agreements.
Proxy materials describe board and shareholder governance for the Maryland corporation. Other disclosures address common stock listed under the SBRA symbol, equity distribution arrangements, debt redemption notices, related financing arrangements and risk or governance matters tied to the company’s REIT structure and healthcare real estate portfolio.
Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. Costa Michael Lourenco reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. (SBRA) reported that Executive VP, CFO & Treasurer Michael Lourenco received a grant of 4,158 stock units of common stock on August 31, 2026. These units were credited as dividend equivalent payments on previously granted stock units and will vest and be paid on the same terms as the original awards.
After this grant, Lourenco holds 469,879 stock units directly, including 286,773 stock units that will settle one-for-one in common shares upon vesting, plus indirect holdings of 784 shares in his IRA and 207 shares in his spouse’s IRA. No Rule 10b5-1 trading plan is reported.
Sabra Health Care REIT, Inc. (symbol: SBRA) is the issuer of record for a Form 4 filing submitted to the SEC. MATROS RICHARD K reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. (SBRA) reported that Chair, CEO and President Richard K. Matros received a grant of 13,867 stock units of common stock on August 31, 2026 as a dividend-equivalent credit on previously granted stock units under the 2009 Performance Incentive Plan. These units will vest and be settled in common shares on the same terms as the original awards, bringing his directly held stock units to 956,268 shares, with an additional 1,857,686 shares held indirectly through the R&A Matros Revocable Trust. No Rule 10b5-1 trading plan is reported.
Sabra Health Care REIT, Inc. generated Q2 2026 total revenues of 235,866 (dollars in thousands), up from 189,150 (dollars in thousands) a year earlier, led by its Senior Housing - Managed portfolio where resident fees and services increased to 128,802 (dollars in thousands) from 78,985 (dollars in thousands). Rental and related revenues were 101,308 (dollars in thousands).
Despite higher revenues, net loss attributable to common stockholders was 25,202 (dollars in thousands) versus net income of 65,542 (dollars in thousands), driven largely by a 102,445 (dollars in thousands) provision for loan losses and other reserves, including a $100.0 million write-off on the Recovery Centers of America mortgage loan following a $200.0 million payoff on a $300.0 million balance. For the first six months, net income attributable was 15,678 (dollars in thousands) compared with 105,846 (dollars in thousands) in the prior-year period.
Sabra continued to reshape its portfolio, investing 287,552 (dollars in thousands) to acquire senior housing and skilled nursing assets, plus $8.2 million in bed rights and land and $16.3 million to purchase operations, while selling seven facilities for 93.6 (dollars in millions) and recording a 37,717 (dollars in thousands) net gain. Net cash provided by operating activities reached 184,182 (dollars in thousands), cash, cash equivalents and restricted cash totaled 238,340 (dollars in thousands), and the company paid $0.60 per share in common dividends year to date with 255,462,756 shares outstanding as of June 30, 2026.
Sabra Health Care REIT, Inc. reported Q2 2026 revenues of $235.9 million, up from $189.2 million a year earlier, but recorded a net loss of $25.2 million or $(0.10) per diluted share, driven largely by a $102.4 million provision for loan losses and other reserves. Cash-based metrics were stronger: Normalized AFFO was $103.5 million, or $0.40 per share, compared with $91.6 million, or $0.38 per share, in Q2 2025, supporting a quarterly dividend of $0.30 per share.
Same-property managed senior housing Cash NOI increased 13.7% year over year, and rent coverage in the triple-net portfolio remained solid, with skilled nursing at 2.49x, senior housing – leased at 1.52x, and behavioral health/specialty at 4.14x. Sabra continued to deploy capital, closing second-quarter senior housing and skilled nursing investments with total commitments of $274.1 million at an initial cash yield of 8.1%, bringing year-to-date investments to $599.0 million at a 7.5% estimated initial cash yield, and has been awarded another $100 million of investments at about 7.7%.
Liquidity was approximately $1.3 billion as of June 30, 2026, including $231.6 million of cash, and Net Debt to Adjusted EBITDA was 4.61x. The board declared a $0.30 quarterly dividend payable August 31, 2026, and Sabra reiterated its full-year 2026 guidance from its July 21, 2026 business update.
Sabra Health Care REIT outlined portfolio and balance-sheet moves and raised its 2026 earnings outlook. It plans to re-tenant all 26 properties leased to Avamere, shifting 22 to Cascadia Healthcare and four to an existing tenant. Upon closing, annualized cash rent from this portfolio is expected to be $53 million, nearly 30% above the $41 million received from Avamere, plus other initiatives adding over $9 million of run-rate cash NOI.
Sabra and Recovery Centers of America agreed to a $200 million cash repayment to settle a $300 million mortgage, reducing Net Debt to EBITDA from 5.0x to 4.8x and lowering behavioral health concentration of Annualized Cash NOI from 13% to 9%. Incorporating these actions and year-to-date performance, 2026 per-share guidance now ranges from $0.37–$0.39 of net income, $1.12–$1.14 of FFO, $1.53–$1.55 of Normalized FFO, $1.58–$1.60 of AFFO and $1.59–$1.61 of Normalized AFFO.
Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Jeffrey A. Malehorn received an equity grant of 8,310 restricted stock units of common stock as compensation. The award was granted under Sabra’s 2009 Performance Incentive Plan and carries no purchase price.
The units vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. After this grant, Malehorn has beneficial ownership of 116,346 shares/units, including 8,310 unvested stock units and 55,016 stock units that have vested but with payment deferred, each unit representing one share of common stock.
Kono Ann reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units of common stock as compensation. The grant was made at no cash cost to her and is structured to vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders' meeting.
Each unit represents the right to receive one share of Sabra’s common stock. Following this grant, Kono has an aggregate 68,186 stock units, including the 8,310 unvested units from this award and 55,016 units that have already vested but for which share delivery has been deferred.
KATZMANN LYNNE S reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT, Inc. director Lynne S. Katzmann received a grant of 8,310 restricted stock units of Common Stock at no cash cost, as part of the company’s 2009 Performance Incentive Plan. These units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.
Each stock unit represents the right to receive one share of common stock. Following this award, Katzmann directly holds 86,121 stock units, including 8,310 unvested units and 55,016 units that have vested but for which payment has been deferred.
FOSTER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Michael J. Foster reported a new equity award and updated holdings. He received a grant of 8,310 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share, increasing his direct ownership to 82,043 shares after the award. The units were granted under the company’s 2009 Performance Incentive Plan and will vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. The filing also shows 42,411.745 shares held indirectly through a 401(k) plan and notes that his equity mix includes 8,310 unvested stock units and 55,016 vested but deferred stock units, each representing the right to receive one share of common stock.
Cusack Catherine reported acquisition or exercise transactions in this Form 4 filing.
Sabra Health Care REIT director Catherine Cusack received a grant of 8,310 restricted stock units of Common Stock. The grant was made at no cash cost per share and increases her direct holdings to 82,056 shares and stock units in total following the transaction.
The restricted stock units were granted under Sabra’s 2009 Performance Incentive Plan. According to the terms, they vest in equal monthly installments beginning on July 17, 2026 and continuing until the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting.
Footnote disclosure indicates her holdings include 8,310 unvested stock units from this grant and 55,016 stock units that have already vested but for which payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s Common Stock.